Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Petra Kolenc-Peitl"'
Autor:
Nic Gillings, Olaug Hjelstuen, Jim Ballinger, Martin Behe, Clemens Decristoforo, Philip Elsinga, Valentina Ferrari, Petra Kolenc Peitl, Jacek Koziorowski, Peter Laverman, Thomas L. Mindt, Oliver Neels, Meltem Ocak, Marianne Patt, Sergio Todde
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-22 (2021)
Abstract This guideline on current good radiopharmacy practice (cGRPP) for small-scale preparation of radiopharmaceuticals represents the view of the Radiopharmacy Committee of the European Association of Nuclear Medicine (EANM). The guideline is lai
Externí odkaz:
https://doaj.org/article/bc7de423197d4be2b0ea1a371b29aa4d
Autor:
Nic Gillings, Sergio Todde, Martin Behe, Clemens Decristoforo, Philip Elsinga, Valentina Ferrari, Olaug Hjelstuen, Petra Kolenc Peitl, Jacek Koziorowski, Peter Laverman, Thomas L. Mindt, Meltem Ocak, Marianne Patt
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 5, Iss 1, Pp 1-29 (2020)
Abstract Background To fulfil good manufacturing requirements, analytical methods for the analysis of pharmaceuticals for human and vetinary use must be validated. The International Conference on Harmonization of Technical Requirements for Registrati
Externí odkaz:
https://doaj.org/article/cc45c06314a7408c8bffce0df6f67c8c
Autor:
Melpomeni Fani, Viktoria Weingaertner, Petra Kolenc Peitl, Rosalba Mansi, Raghuvir H. Gaonkar, Piotr Garnuszek, Renata Mikolajczak, Doroteja Novak, Urban Simoncic, Alicja Hubalewska-Dydejczyk, Christine Rangger, Piriya Kaeopookum, Clemens Decristoforo
Publikováno v:
Pharmaceuticals, Vol 14, Iss 1, p 19 (2020)
Recently, radiolabelled antagonists targeting somatostatin receptors subtype 2 (SST2) in neuroendocrine neoplasms demonstrated certain superior properties over agonists. Within the ERA-PerMED project “TECANT” two 99mTc-Tetramine (N4)-derivatized
Externí odkaz:
https://doaj.org/article/27eca23b87c94adc870aecec8c017aaf
Autor:
Marko Krošelj, Petra Kolenc Peitl, Aljaž Sočan, Marijana Leskovec, Irena Mlinarič-Raščan, Tanja Gmeiner
Publikováno v:
Zdravniški Vestnik, Vol 87, Iss 9-10, Pp 439–452-439–452 (2018)
Nuklearna medicina pri obravnavi onkoloških bolnikov omogoča slikovni prikaz oziroma lokalizacijo tumorjev, ciljano zdravljenje ter spremljanje uspešnosti zdravljenja. Visoko specifične radiooznačene peptidne učinkovine lahko izkoristimo za cil
Externí odkaz:
https://doaj.org/article/633f3bf3b4be4869917ffada69c6f73f
Autor:
Uroš Javornik, Marko Anderluh, Janez Plavec, Tihomir Tomašič, Petra Kolenc Peitl, Marko Kroselj, Doroteja Novak
Publikováno v:
ChemMedChem. 16:155-163
The cholecystokinin-2/gastrin receptor (CCK2 R) is considered a suitable target for the development of radiolabelled antagonists, due to its overexpression in various tumours, but no such compounds are available in clinical use. Therefore, we designe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b4c4f78197b3c0fa5b51c814874c608
https://doi.org/10.1002/cmdc.202000392
https://doi.org/10.1002/cmdc.202000392
Publikováno v:
Drug Discovery Today. 25:1322-1336
The widespread involvement of the cholecystokinin-2/gastrin receptor (CCK2R) in multiple (patho)physiological processes has propelled extensive searches for nonpeptide small-molecule CCK2R antagonists. For the past three decades, considerable researc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a587f390c08b9aa997e1c058ef025e1a
https://doi.org/10.1016/j.drudis.2020.05.008
https://doi.org/10.1016/j.drudis.2020.05.008
Publikováno v:
Pharmaceuticals, Vol 10, Iss 1, p 30 (2017)
Abstract: Nuclear medicine plays a pivotal role in the management of patients affected by neuroendocrine neoplasms (NENs). Radiolabeled somatostatin receptor analogs are by far the most advanced radiopharmaceuticals for diagnosis and therapy (radioth
Externí odkaz:
https://doaj.org/article/2fa44008eda34132ba428db268072472
Autor:
Sergio Todde, Martin Béhé, Thomas L. Mindt, Marianne Patt, Clemens Decristoforo, Petra Kolenc Peitl, Nic Gillings, Meltem Ocak, Jacek Koziorowski, Peter Laverman, James R. Ballinger, Oliver C. Neels, Valentina Ferrari, Olaug Hjelstuen, Philip H. Elsinga
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-22 (2021)
EJNMMI Radiopharmacy and Chemistry 6(2021), 8
EJNMMI radiopharmacy and chemistry, 6, 1
EJNMMI Radiopharmacy and Chemistry, 6(1):8. Springer
EJNMMI Radiopharmacy and Chemistry
EJNMMI radiopharmacy and chemistry, 6
EJNMMI Radiopharmacy and Chemistry 6(2021), 8
EJNMMI radiopharmacy and chemistry, 6, 1
EJNMMI Radiopharmacy and Chemistry, 6(1):8. Springer
EJNMMI Radiopharmacy and Chemistry
EJNMMI radiopharmacy and chemistry, 6
Contains fulltext : 232903.pdf (Publisher’s version ) (Open Access) This guideline on current good radiopharmacy practice (cGRPP) for small-scale preparation of radiopharmaceuticals represents the view of the Radiopharmacy Committee of the European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46c9796f5a477aa6f2d7937795994b5d
https://doi.org/10.1186/s41181-021-00123-2
https://doi.org/10.1186/s41181-021-00123-2
Autor:
Doroteja, Novak, Tihomir, Tomašič, Marko, Krošelj, Uroš, Javornik, Janez, Plavec, Marko, Anderluh, Petra, Kolenc Peitl
Publikováno v:
ChemMedChem. 16(1)
The cholecystokinin-2/gastrin receptor (CCK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0d81a2b808c0cf64ec07e92bcf5c9bf4
https://pubmed.ncbi.nlm.nih.gov/32643833
https://pubmed.ncbi.nlm.nih.gov/32643833
Publikováno v:
Drug discovery today. 25(8)
The widespread involvement of the cholecystokinin-2/gastrin receptor (CCK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f1301854bbf1d2feb5ff684cf785bfb
https://pubmed.ncbi.nlm.nih.gov/32439608
https://pubmed.ncbi.nlm.nih.gov/32439608